Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:50:46.761Z.
Calculation as of: 2026-10-06T12:50:46.761Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d9f471510e2ba483dadfaa738129fdacbeb72ec081face8194c47abf0e776528
EARNINGS YIELD
N/A
Market Cap
$6.76M
Earnings Yield
N/A
TTM Avg
2.14%
3Y Avg
1.65%
5Y Avg
1.48%
Market Cap
$6.88M
Earnings Yield
N/A
TTM Avg
21.79%
3Y Avg
16.65%
5Y Avg
16.65%
Market Cap
$6.44M
Earnings Yield
N/A
TTM Avg
0.03%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$7.03M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | $6.72M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | N/A | 2.14% | 1.65% | 1.48% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | 21.79% | 16.65% | 16.65% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 0.03% | 0.01% | 0.01% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.34M | N/A | 0.84% | 1.16% | 1.47% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | N/A | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
